Antiviral Medications - Hepatitis C, HIV, Herpes Treatments
Antiviral medications treat infections caused by viruses — obligate intracellular parasites that hijack host cell machinery to replicate. Unlike bacteria, viruses lack their own metabolic processes, making selective targeting more challenging. Despite this, modern antivirals have transformed several conditions from chronic life-shortening illnesses to curable or well-controlled diseases. This catalogue covers therapy for HIV/AIDS, herpes simplex virus (HSV), varicella-zoster virus (VZV), hepatitis B and C, and influenza/parkinsonism.
The most dramatic transformations: HIV/AIDS went from rapidly fatal in the 1980s-90s to a managed chronic condition with near-normal life expectancy using modern combination antiretroviral therapy (cART); chronic hepatitis C went from progressive liver disease to a >95% curable condition with 8-12 weeks of oral direct-acting antivirals (sofosbuvir / Sovaldi / Hepcinat, ledipasvir, daclatasvir); and herpes infections can be effectively suppressed with chronic acyclovir-family therapy.
Choosing the right antiviral depends on the specific virus, disease stage, prior treatment history, drug resistance, comorbidities, and reproductive plans. Most antiviral therapies require specialist supervision — infectious disease, hepatology, or HIV medicine — with regular monitoring of viral loads, organ function, drug levels, and resistance testing. Generic versions of branded antivirals from established Indian manufacturers (Cipla, Hetero, Mylan, Natco) provide access to expensive originals at substantially lower cost.
🧐 Conditions This Category Treats
HIV/AIDS uses combination antiretroviral therapy (cART) targeting multiple viral replication steps simultaneously. The catalogue includes representatives from several classes: nucleoside reverse transcriptase inhibitors (NRTIs) — lamivudine in Epivir, lamivudine/zidovudine combination in Combivir, zidovudine in Retrovir, stavudine in Zerit; non-nucleoside reverse transcriptase inhibitors (NNRTIs) — efavirenz in Sustiva; integrase inhibitors — dolutegravir alone in Xapavir or combined with lamivudine/tenofovir in Viropil; modern preferred regimens use single-tablet once-daily combinations.
Herpes simplex virus (HSV) infections — both oral (cold sores) and genital herpes — affect billions globally. Treatment with acyclovir (Zovirax), famciclovir (Famvir, Famcimac, Virovir), or valacyclovir (Valtrex) shortens outbreaks, reduces severity, and when used continuously reduces frequency and transmission risk. Modern guidelines support both episodic (treat outbreaks as they occur) and chronic suppressive (daily preventive) strategies. Varicella-zoster virus (shingles) responds to the same drugs at higher doses, ideally started within 72 hours of rash onset to reduce post-herpetic neuralgia risk.
Chronic hepatitis C is now routinely cured with 8-12 weeks of direct-acting antiviral therapy — sofosbuvir (Sovaldi / Hepcinat / Hepcvir) alone or combined with other agents (ledipasvir / Harvoni, daclatasvir, velpatasvir). Ribavirin (Copegus / Rebetol / Ribasure) is added in specific cases, particularly genotype 3 with cirrhosis. Cure rates exceed 95% in most patient populations. Chronic hepatitis B uses long-term nucleotide/nucleoside analogues including adefovir (Hepsera), tenofovir, and entecavir to suppress viral replication and reduce progression to cirrhosis and hepatocellular carcinoma.
Other indications: Symmetrel (amantadine) historically treated influenza A and has continued use in Parkinson disease (different mechanism). Aralen (chloroquine) — primarily an antimalarial — has antiviral activity in some contexts and is used in autoimmune conditions like systemic lupus erythematosus and rheumatoid arthritis as a DMARD.
💊 How Modern Antiviral Treatment Works
Nucleoside/nucleotide analogues (acyclovir, valacyclovir, famciclovir; lamivudine, zidovudine, tenofovir; sofosbuvir) are "sheep in wolves' clothing" — structural mimics of natural nucleotides that get incorporated into viral DNA/RNA, causing chain termination and stopping replication. The therapeutic index depends on selective uptake or activation by viral enzymes, which limits effects on host cells. Side effects relate to incomplete selectivity — renal effects (tenofovir, acyclovir), mitochondrial toxicity (stavudine, zidovudine), GI upset.
Non-nucleoside reverse transcriptase inhibitors (NNRTIs) like efavirenz (Sustiva) bind allosterically to HIV reverse transcriptase, preventing its function without competing for nucleotide binding. Highly specific for HIV; main concerns are CNS effects (vivid dreams, dizziness usually settling after weeks), rash, and rare hepatotoxicity. Integrase strand-transfer inhibitors (dolutegravir, raltegravir) block integration of viral DNA into host genome — modern HIV therapy increasingly uses integrase inhibitors as backbone because of high potency and favourable resistance profile.
Direct-acting antivirals (DAAs) for hepatitis C revolutionised treatment in 2014. Sofosbuvir targets viral NS5B polymerase; ledipasvir, daclatasvir target NS5A; protease inhibitors target NS3/4A. Combinations of 2-3 agents covering different targets achieve sustained viral response (cure) in 95%+ of patients across all genotypes — with minimal side effects in 8-12 weeks. This represents one of medicine's great success stories. Ribavirin, a nucleoside analogue used as adjunct in some HCV regimens and respiratory syncytial virus (RSV), has more side effects (anaemia, teratogenicity) but remains useful in specific contexts.
💊 Drug Classes in This Category
| Class | Indication | Examples |
|---|---|---|
| HSV/VZV antivirals | Genital herpes, cold sores, shingles — episodic or suppressive | Zovirax (acyclovir), Valtrex (valacyclovir), Famvir, Famcimac, Virovir (famciclovir) |
| HIV NRTIs | HIV combination therapy backbone; PEP; mother-to-child transmission prevention | Epivir (lamivudine), Combivir (lamivudine/zidovudine), Retrovir (zidovudine), Zerit (stavudine) |
| HIV NNRTI | HIV combination therapy; older single-tablet regimens | Sustiva (efavirenz) |
| HIV integrase inhibitors | Modern HIV first-line; high genetic barrier to resistance | Xapavir (dolutegravir), Viropil (dolutegravir/lamivudine/tenofovir) |
| Hepatitis C DAAs (NS5B) | Chronic hepatitis C cure (8-12 week courses) | Hepcinat, Hepcvir (sofosbuvir) |
| Ribavirin (broad-spectrum) | Hepatitis C adjunct, RSV, severe viral fevers | Copegus, Rebetol, Ribasure (ribavirin) |
| Hepatitis B nucleotide analogue | Chronic hepatitis B suppression in HBV monoinfection or HIV-HBV coinfection | Hepsera (adefovir) |
| Adamantanes | Parkinson disease, fatigue in MS; historical use in influenza A | Symmetrel (amantadine) |
| 4-aminoquinoline | Malaria prophylaxis and treatment; SLE, RA (DMARD use) | Aralen (chloroquine) |
✅ How to Choose
- 👿 First episode of genital herpes → Valtrex (valacyclovir) 1 g twice daily for 7-10 days, or acyclovir 400 mg three times daily.
- 💤 Recurrent genital herpes (frequent outbreaks) → Valtrex 500 mg daily for suppression; reduces outbreaks by 70-80% and transmission risk by ~50%.
- 🥕 Shingles (within 72 hours of rash) → Famvir (famciclovir) 500 mg three times daily for 7 days, or valacyclovir 1 g three times daily. Reduces post-herpetic neuralgia.
- 🧐 Newly diagnosed HIV (treatment-naive) → Viropil (dolutegravir + lamivudine + tenofovir) single-tablet once-daily — modern first-line. Specialist supervision.
- 🥩 Chronic hepatitis C (any genotype) → Hepcinat / Hepcvir (sofosbuvir) + daclatasvir or ledipasvir for 8-12 weeks; cure rate over 95%. Specialist supervision; check viral load 12 weeks post-treatment.
- 🥩 Chronic hepatitis B (active replication) → tenofovir or entecavir first-line; Hepsera (adefovir) retains specific roles. Lifelong therapy in most cases.
- 🌍 Travel to malaria endemic region (chloroquine-sensitive areas) → Aralen (chloroquine) prophylaxis; check current resistance patterns.
❓ Frequently Asked Questions
Can hepatitis C really be cured in 12 weeks?
Yes — over 95% cure rate with modern direct-acting antivirals (sofosbuvir-based regimens) in most patient populations. This is one of the great achievements of modern medicine. Cure is defined as undetectable virus 12+ weeks after treatment completion (sustained virologic response, SVR12). Liver damage that occurred before treatment may not fully reverse, but viral elimination prevents further progression.
Should I take daily suppressive therapy for genital herpes?
Worth considering if you have 4+ outbreaks per year, severe outbreaks, or want to reduce transmission risk to partner. Daily valacyclovir 500 mg reduces outbreaks by 70-80% and transmission to seronegative partners by approximately 50%. Episodic treatment (taking medication only during outbreaks) is appropriate for less frequent outbreaks.
Why is HIV not curable yet?
HIV integrates into the host genome and creates latent reservoirs in long-lived cells that current therapy cannot reach. Stopping treatment allows virus to rebound from reservoirs within weeks. Research on cure approaches (gene therapy, latency reversal, broadly neutralising antibodies, allogeneic stem cell transplantation) continues but is not yet ready for general use. Lifelong suppressive therapy remains the standard.
Is amantadine still used for flu?
Rarely. Modern influenza strains are largely resistant to amantadine. It is now mainly used for Parkinson disease and Parkinson-like symptoms, multiple sclerosis fatigue, and rarely other indications. For influenza, modern options include oseltamivir (Tamiflu), zanamivir, baloxavir.
What about COVID-19?
This catalogue does not include COVID-19-specific antivirals (Paxlovid / nirmatrelvir-ritonavir, molnupiravir, remdesivir). These remain available through standard prescription channels with infectious disease guidance. Vaccination remains the most important COVID-19 prevention.
Can these antivirals interact with my other medications?
Yes — many significant interactions. Efavirenz induces CYP3A4, reducing levels of many drugs including hormonal contraceptives. Ritonavir-boosted protease inhibitors inhibit CYP3A4 extensively, raising levels of statins, calcium channel blockers, anticonvulsants. Acyclovir family can affect kidney function. Always provide complete medication list to every prescriber.
🩺 When to See a Healthcare Provider
Antiviral therapy typically requires specialist coordination: HIV medicine for HIV, hepatology for hepatitis B/C, infectious disease for complex viral infections. Routine monitoring varies by drug but typically includes viral load, CD4 count (HIV), liver function, kidney function, and resistance testing. Seek prompt evaluation for: HIV/HBV/HCV diagnosis, severe HSV outbreak with systemic symptoms, shingles within 72 hours, suspected medication side effects, pregnancy planning while on antivirals.
HIV testing should be routine in adults regardless of perceived risk. Hepatitis C testing recommended at least once in all adults (single test enough). Universal hepatitis B vaccination available in most regions. Pre-exposure prophylaxis (PrEP) with tenofovir/emtricitabine combination is highly effective for HIV prevention in high-risk individuals.
📚 Related Articles
- 📖 Shingles: More Than a Skin Rash
- 📖 Hepcinat Cheap: How the Hepatitis C Cure Became Affordable
- 📖 Hepatitis C Explained: The Disease and Its Cure with Sofosbuvir
- 📖 What is Generic Hepcinat
- 📖 Valacyclovir (Valtrex): Treatment Guide
- 📖 Valtrex (Valacyclovir) FAQ: Your Real Questions Answered
- 🔗 Browse all RXshop articles



























